Daptomycin and Keflex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Daptomycin (daptomycin) and Keflex (cephalexin). Common drug interactions include drug resistance among females and hepatotoxicity among males.

The phase IV clinical study analyzes what interactions people have when they take Daptomycin and Keflex. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Daptomycin?

Daptomycin has active ingredients of daptomycin. eHealthMe is studying from 7,879 Daptomycin users. Check the latest studies of Daptomycin.

What is Keflex?

Keflex has active ingredients of cephalexin. It is often used in infection. eHealthMe is studying from 15,844 Keflex users. Check the latest studies of Keflex.



On Jul, 30, 2026

21 people who take Daptomycin and Keflex together, and have interactions are studied.

Daptomycin and Keflex drug interactions.

What are the common drug interactions of Daptomycin and Keflex, by gender? *:

female:

  1. Drug resistance (reduction in effectiveness of a drug)
  2. Dry mouth
  3. Dysmenorrhoea (painful menstruation)
  4. Dyspepsia (indigestion)
  5. Dyspnoea exertional (breathlessness or shortness of breath)
  6. Enterococcal infection
  7. Eosinophilia (eosinophil count in the peripheral blood exceeds)
  8. Epstein-barr viraemia
  9. Exposure to communicable disease
  10. Eye disorder

male:

  1. Hepatotoxicity (chemical-driven liver damage)
  2. Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
  3. Anion gap increased
  4. Anxiety
  5. Aspartate aminotransferase increased
  6. Asthenia (weakness)
  7. Back disorder
  8. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  9. Depression
  10. Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)

What are the common drug interactions of Daptomycin and Keflex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Idiopathic intracranial hypertension (elevated cerebrospinal fluid pressure of unknown cause)
  2. Infectious pleural effusion (infectious fluid in the lung)
  3. Postoperative wound infection
  4. Staphylococcal infection (an infection with staphylococcus bacteria)
  5. Chest pain
  6. Headache (pain in head)
  7. Hypocalcaemia (levels of calcium in blood serum are abnormally low)
  8. Intracranial pressure increased (high pressure inside the skull and thus in the brain tissue and cerebrospinal fluid)
  9. Meningitis viral (viral inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)
  10. Rectal haemorrhage (bleeding from anus)

30-39:

  1. Device related infection
  2. Wound dehiscence (a surgical incision reopens either internally or externally)
  3. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  4. Injury
  5. Pulmonary embolism (blockage of the main artery of the lung)
  6. Thrombophlebitis superficial (swelling (inflammation) of a superficial vein caused by a blood clot)

40-49:

  1. Asthma

50-59:

  1. Dry mouth
  2. Dysmenorrhoea (painful menstruation)
  3. Emotional distress
  4. Enterococcal infection
  5. Eosinophilia (eosinophil count in the peripheral blood exceeds)
  6. Epstein-barr viraemia
  7. Exposure to communicable disease
  8. Fear
  9. Frequent bowel movements
  10. Gastritis (inflammation of stomach)

60+:

  1. Hepatotoxicity (chemical-driven liver damage)
  2. Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
  3. Anaemia (lack of blood)
  4. Anal abscess
  5. Anaphylactic reaction (serious allergic reaction)
  6. Anion gap increased
  7. Aspartate aminotransferase increased
  8. Back disorder
  9. Blood pressure increased
  10. Catheter site erythema (redness of skin at catheter site)

What are the existing conditions these people have? *

  1. Pain: 8 people, 38.10%
  2. Urinary Tract Infection: 7 people, 33.33%
  3. Stress And Anxiety: 7 people, 33.33%
  4. Constipation: 7 people, 33.33%
  5. Nausea (feeling of having an urge to vomit): 7 people, 33.33%
  6. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 6 people, 28.57%
  7. Hypogonadism (reduction or absence of hormone secretion or other physiological activity of the gonads (testes or ovaries)): 6 people, 28.57%
  8. Hypokalemia (low potassium): 6 people, 28.57%
  9. Hypoparathyroidism (inadequate secretion of parathyroid hormone resulting in abnormally low levels of calcium in the blood): 6 people, 28.57%
  10. Headache (pain in head): 6 people, 28.57%

* Approximation only. Some reports may have incomplete information.

Do you take Daptomycin and Keflex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Daptomycin and Keflex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Daptomycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Keflex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Daptomycin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Keflex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on daptomycin and cephalexin (the active ingredients of Daptomycin and Keflex, respectively), and Daptomycin and Keflex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: